Impact of concurrent medications use on outcome of pancreatic cancer: SEER Medicare analysis.

Authors

Shaalan Beg

Muhammad Shaalan Beg

Division of Hematology/Oncology, The University of Texas Southwestern Medical Center, Dallas, TX

Muhammad Shaalan Beg , Tyler Stewart , Ang Gao , Chul Ahn , Jarett Berry , Eric Mortensen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 378)

DOI

10.1200/jco.2016.34.4_suppl.378

Abstract #

378

Poster Bd #

J14

Abstract Disclosures

Similar Posters

First Author: Adetunji T. Toriola

First Author: Chenwi Ambe

First Author: Do-Youn Oh

Poster

2020 Gastrointestinal Cancers Symposium

Changes in glucose tolerance after pancreatectomy in patients with pancreatic ductal adenocarcinoma.

Changes in glucose tolerance after pancreatectomy in patients with pancreatic ductal adenocarcinoma.

First Author: Sachiyo Shirakawa